Global profile of genes regulated by securin by unknown
BioMed Central
Page 1 of 1
(page number not for citation purposes)
BMC Bioinformatics
Open AccessPoster presentation
Global profile of genes regulated by securin
Sham S Kakar*, Siva K Panguluri and Sabine J Waigel
Address: Department of Medicine, James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA
Email: Sham S Kakar* - sham.kakar@louisville.edu
* Corresponding author    
Securin is a proto-oncogene that plays a pivotal role in cell
division, sister chromatids separation and pancreatic beta
cell proliferation. Over-expression of securin in normal
cells results in cellular transformation and development
on tumor in nude mice. On the other hand, depletion of
securin from cancer cells results in suppression of tumor
and reversal of cancer phenotype in vitro and in vivo. In
many cases securin acts as a transcription factor and regu-
lates the expression of important target genes. However,
only a few target genes have been identified. Therefore, we
used a quantitative microarray assay to identify the genes
that are regulated by securin in a human embryonic kid-
ney cell line (HEK293) that do not express securin or
express at a very low level. We infected HEK293 cells with
empty adenovirus, adenovirus expressing GFP or adenovi-
rus expressing securin. Infection of cells with adenovirus
expressing securin for 48 h resulted in alterations in the
levels of expression of genes that ranged in magnitude
from 1.1- to 42-fold, with a total of 313 genes exhibiting
a p value < 0.05 compared to control adenovirus or aden-
ovirus expressing GFP protein. Infection of HEK293 with
adenovirus expressing securin was found to affect the
expression of a diverse range of genes, including onco-
genes and those that encode transcription factors, ion
channel proteins, and cytoskeletal proteins as well as
other proteins that are involved in signal transduction, the
cell cycle, cell proliferation and apoptosis. The altered
expression of some of these genes that were found by
microarray analysis to be regulated by securin was con-
firmed by semiquantitative reverse transcriptase-polymer-
ase chain reaction. The application of the microarray
technique should prove to be a powerful tool for future
analysis of the mechanisms by which securin regulates
tumorigenesis.
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